American Neurotology Society, American Otological Society, and American Academy of Otolaryngology – Head and Neck Foundation Guide to Enhance Otologic and Neurotologic Care During the COVID-19 Pandemic
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
<p class="first" id="d15824702e557">: This combined American Neurotology Society,
American Otological Society, and American
Academy of Otolaryngology - Head and Neck Surgery Foundation document aims to provide
guidance during the coronavirus disease of 2019 (COVID-19) on 1) "priority" of care
for otologic and neurotologic patients in the office and operating room, and 2) optimal
utilization of personal protective equipment. Given the paucity of evidence to inform
otologic and neurotologic best practices during COVID-19, the recommendations herein
are based on relevant peer-reviewed articles, the Centers for Disease Control and
Prevention COVID-19 guidelines, United States and international hospital policies,
and expert opinion. The suggestions presented here are not meant to be definitive,
and best practices will undoubtedly change with increasing knowledge and high-quality
data related to COVID-19. Interpretation of this guidance document is dependent on
local factors including prevalence of COVID-19 in the surgeons' local community. This
is not intended to set a standard of care, and should not supersede the clinician's
best judgement when managing specific clinical concerns and/or regional conditions.Access
to otologic and neurotologic care during and after the COVID-19 pandemic is dependent
upon adequate protection of physicians, audiologists, and ancillary support staff.
Otolaryngologists and associated staff are at high risk for COVID-19 disease transmission
based on close contact with mucosal surfaces of the upper aerodigestive tract during
diagnostic evaluation and therapeutic procedures. While many otologic and neurotologic
conditions are not imminently life threatening, they have a major impact on communication,
daily functioning, and quality of life. In addition, progression of disease and delay
in treatment can result in cranial nerve deficits, intracranial and life-threatening
complications, and/or irreversible consequences. In this regard, many otologic and
neurotologic conditions should rightfully be considered "urgent," and almost all require
timely attention to permit optimal outcomes. It is reasonable to proceed with otologic
and neurotologic clinic visits and operative cases based on input from expert opinion
of otologic care providers, clinic/hospital administration, infection prevention and
control specialists, and local and state public health leaders. Significant regional
variations in COVID-19 prevalence exist; therefore, physicians working with local
municipalities are best suited to make determinations on the appropriateness and timing
of otologic and neurotologic care.
</p>
In December 2019, novel coronavirus (2019-nCoV)-infected pneumonia (NCIP) occurred in Wuhan, China. The number of cases has increased rapidly but information on the clinical characteristics of affected patients is limited.
Abstract Background The initial cases of novel coronavirus (2019-nCoV)–infected pneumonia (NCIP) occurred in Wuhan, Hubei Province, China, in December 2019 and January 2020. We analyzed data on the first 425 confirmed cases in Wuhan to determine the epidemiologic characteristics of NCIP. Methods We collected information on demographic characteristics, exposure history, and illness timelines of laboratory-confirmed cases of NCIP that had been reported by January 22, 2020. We described characteristics of the cases and estimated the key epidemiologic time-delay distributions. In the early period of exponential growth, we estimated the epidemic doubling time and the basic reproductive number. Results Among the first 425 patients with confirmed NCIP, the median age was 59 years and 56% were male. The majority of cases (55%) with onset before January 1, 2020, were linked to the Huanan Seafood Wholesale Market, as compared with 8.6% of the subsequent cases. The mean incubation period was 5.2 days (95% confidence interval [CI], 4.1 to 7.0), with the 95th percentile of the distribution at 12.5 days. In its early stages, the epidemic doubled in size every 7.4 days. With a mean serial interval of 7.5 days (95% CI, 5.3 to 19), the basic reproductive number was estimated to be 2.2 (95% CI, 1.4 to 3.9). Conclusions On the basis of this information, there is evidence that human-to-human transmission has occurred among close contacts since the middle of December 2019. Considerable efforts to reduce transmission will be required to control outbreaks if similar dynamics apply elsewhere. Measures to prevent or reduce transmission should be implemented in populations at risk. (Funded by the Ministry of Science and Technology of China and others.)
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.